首页> 外文期刊>Advances in Therapy >Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial Inflammation
【24h】

Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial Inflammation

机译:铜绿假单胞菌定植的重症COPD患者的妥布霉素雾化剂溶液:对支气管炎症的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Airway colonization with Pseudomonas aeruginosa is frequent in severe chronic obstructive pulmonary disease (COPD) and may lead to progressive inflammatory damage. Inhaled Tobramycin Nebulizer Solution (TNS; a preservative-free formulation) is an effective therapy in chronic P aeruginosa infection in cystic fibrosis and bronchiectasis. In this study we aimed to investigate the effects of a TNS short course on inflammatory markers in bronchial secretions from multiresistant P aeruginosa-colonized patients with severe COPD. To the authors’ knowledge, this is the first study to examine this in cases of severe COPD.
机译:在严重的慢性阻塞性肺疾病(COPD)中,铜绿假单胞菌在气道中的定植频繁,并可能导致进行性炎症损害。吸入妥布霉素雾化器溶液(TNS;无防腐剂)是治疗慢性铜绿假单胞菌感染,囊性纤维化和支气管扩张的有效疗法。在这项研究中,我们旨在研究TNS短期疗程对多药耐药铜绿假单胞菌加重的COPD患者支气管分泌物中炎症标志物的影响。据作者所知,这是第一个针对重度COPD病例进行研究的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号